The natural history of community-acquired common colds symptoms assessed over 4-years
- PMID: 25756083
- DOI: 10.4193/Rhino14.149
The natural history of community-acquired common colds symptoms assessed over 4-years
Abstract
Background: The common cold is the most frequently experienced infection among humans, but limited data exist to characterize the onset, duration, severity and intersection of symptoms in community-acquired colds. A more complete understanding of the symptom frequency and burden in naturally occurring colds is needed.
Methodology: We characterized common cold symptoms from 226 cold episodes experienced by 104 male or female subjects. Subjects were enrolled in the work environment in an attempt to start symptom evaluation (frequency and severity) at the earliest sign of their cold. We also assessed the symptom that had the greatest impact on the subject by asking them to identify their single most bothersome symptom.
Results: Symptom reporting started within 24 hours of cold onset for most subjects. Sore throat was a harbinger of the illness but was accompanied by multiple symptoms, including nasal congestion, runny nose and headache. Cough was not usually the most frequent symptom, but was present throughout the cold, becoming most bothersome later in the cold. Nasal congestion, pain (eg, sore throat, headache, muscle pains) or feverishness and secretory symptoms (eg, runny nose, sneezing), and even cough, were simultaneously experienced with high incidence over the first 4 days of illness. The single most bothersome symptom was sore throat on day 1, followed by nasal congestion on days 2-5 and cough on days 6 and 7.
Conclusion: There is substantial overlap in the appearance of common cold symptoms over the first several days of the common cold. Nasal congestion, secretory and pain symptoms frequently occur together, with cough being somewhat less prominent, but quite bothersome when present. These data establish the typical symptomatology of a common cold and provide a foundation for the rational treatment of cold symptoms typically experienced by cold sufferers.
Similar articles
-
Consumer attitudes on cough and cold: US (ACHOO) survey results.Curr Med Res Opin. 2015 Aug;31(8):1527-38. doi: 10.1185/03007995.2014.1002558. Curr Med Res Opin. 2015. PMID: 25535904
-
Symptom profile of common colds in school-aged children.Pediatr Infect Dis J. 2008 Jan;27(1):8-11. doi: 10.1097/INF.0b013e31814847d9. Pediatr Infect Dis J. 2008. PMID: 18162930
-
Common cold symptoms in children: results of an Internet-based surveillance program.J Med Internet Res. 2014 Jun 19;16(6):e144. doi: 10.2196/jmir.2868. J Med Internet Res. 2014. PMID: 24945090 Free PMC article.
-
Understanding the symptoms of the common cold and influenza.Lancet Infect Dis. 2005 Nov;5(11):718-25. doi: 10.1016/S1473-3099(05)70270-X. Lancet Infect Dis. 2005. PMID: 16253889 Free PMC article. Review.
-
Effects on the nasal mucosa of upper respiratory viruses (common cold).Dan Med Bull. 1994 Apr;41(2):193-204. Dan Med Bull. 1994. PMID: 8039434 Review.
Cited by
-
Early intervention with ColdZyme mouth spray after self-diagnosis of common cold: A randomized, double-blind, placebo-controlled study.PLoS One. 2023 Jan 18;18(1):e0279204. doi: 10.1371/journal.pone.0279204. eCollection 2023. PLoS One. 2023. PMID: 36652464 Free PMC article. Clinical Trial.
-
Aromatic ointments for the common cold: what does the science say?Drugs Context. 2022 Aug 1;11:2022-5-6. doi: 10.7573/dic.2022-5-6. eCollection 2022. Drugs Context. 2022. PMID: 35975030 Free PMC article. Review.
-
Early intervention with a glycerol throat spray containing cold-adapted cod trypsin after self-diagnosis of common cold: A randomised trial.PLoS One. 2022 Jul 5;17(7):e0270699. doi: 10.1371/journal.pone.0270699. eCollection 2022. PLoS One. 2022. PMID: 35789217 Free PMC article. Clinical Trial.
-
ColdZyme® reduces viral load and upper respiratory tract infection duration and protects airway epithelia from infection with human rhinoviruses.J Physiol. 2025 Mar;603(6):1483-1501. doi: 10.1113/JP288136. Epub 2025 Feb 28. J Physiol. 2025. PMID: 40019230 Free PMC article. Clinical Trial.
-
Postmarketing Reevaluation of Chinese Traditional Therapy Kangbingdu Oral Liquid in the Treatment of the Common Cold.Evid Based Complement Alternat Med. 2022 Sep 1;2022:9968171. doi: 10.1155/2022/9968171. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 36091597 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical